Regional Monitoring EECA
by ECUO PLWH
Showing 1-20 of 20 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of LatviaGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.6193030348.571348.572015Not specifiedNot specifiedNot specified
2Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.43331590301353689VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
3Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab0.5167303015.5115.52015Not specifiedNot specifiedNot specified
4Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.166719500030425650027625002015Not specifiedNot specifiedNot specified
5Kyrgyz RepublicGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.5167-3015.5--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
6Republic of LithuaniaGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.13733030334.121334.12Viiv Healthcare UK Limited2015Not specifiedYesNot specified
7Republiс of AzerbaijanGovernmentViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab1.7167219603051.5732376982015YesYesNot specified
8Russian FederationGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab4.002436197030120.06145399174566042015Not specifiedNot specifiedNot specified
9UkraineGovernmentGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab0.97971719303029.395731168434.092015Not specifiedNot specifiedNot specified
10Republic of MoldovaGlobal FundHetero labs Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.56550703016.951692864.55IDA Foundation2015Not specifiedYesNot specified
11Republic of PolandGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.166718000304256002550002015Not specifiedNot specifiedNot specified
12Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.1667660003042522009350002015Not specifiedNot specifiedNot specified
13Republic of MoldovaGlobal FundHetero labs Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.56550403016.951682847.62015Not specifiedYesNot specified
14Republic of KazakhstanGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab0.377730474003011.331015801150901.382015Not specifiedNot specifiedNot specified
15UkraineGlobal FundGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab1.02303030.6130.62015Not specifiedNot specifiedNot specified
16Republic of MoldovaGlobal FundCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.1221480607.23582577.62015Not specifiedYesNot specified
17Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC60mg+30mg tab0.083360605152015Not specifiedNot specifiedNot specified
18Kyrgyz RepublicGlobal FundCipla LtdAbamune-L BabyAbacavir+Lamivudine - FDC60mg+30mg tab0.0833282060547235UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
19UkraineGovernmentCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.097264440605.8310746261.422015Not specifiedNot specifiedNot specified
20Republic of MoldovaGlobal FundCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.1221060607.23512527.22015Not specifiedYesNot specified